Literature DB >> 20600673

Activation of eukaryotic initiation factor-2 α-kinases in okadaic acid-treated neurons.

S M Kim1, S Y Yoon, J E Choi, J S Park, J M Choi, T Nguyen, D H Kim.   

Abstract

Phosphorylation of eukaryotic initiation factor-2 alpha (eIF2 alpha) is increased in Alzheimer's disease (AD) and this protein can be phosphorylated by several kinases, including double-stranded RNA-dependent protein kinase (PKR), PKR-like endoplasmic reticulum kinase (PERK), amino acids-regulated eIF2 alpha kinase (GCN2) and heme-regulated eIF2 alpha kinase (HRI). PKR and PERK especially are activated in the AD brain, and GCN2 is reported to increase presenilin-1 (PS1) activity. Okadaic acid (OA), a protein phosphatase-2A (PP2A) inhibitor, is known to increase tau phosphorylation, beta-amyloid (A beta) deposition and neuronal death, which are the pathological characteristics of AD. Here, we show that the phosphorylation of eIF2 alpha is increased and its kinases, PKR, PERK and GCN2 are activated in rat neurons by OA. Activating transcription factor (ATF4) which induces apoptosis in response to eIF2 alpha phosphorylation was increased and translocated to nuclei in OA-treated neurons. These results suggest that the successive events of activation of eIF2 alpha kinases and eIF2 alpha phosphorylation leading to ATF4 nuclear translocation may contribute to neuronal death. However, PKR inhibitors did not reduce eIF2 alpha phosphorylation or neuronal toxicity despite inhibiting PKR activity. These results suggest that PKR might not be the most responsible kinase for eIF2 alpha phosphorylation or cell death in PP2A-inhibited conditions such as AD. (c) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20600673     DOI: 10.1016/j.neuroscience.2010.06.016

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

Review 1.  The Integrated Stress Response and Phosphorylated Eukaryotic Initiation Factor 2α in Neurodegeneration.

Authors:  Sarah Bond; Claudia Lopez-Lloreda; Patrick J Gannon; Cagla Akay-Espinoza; Kelly L Jordan-Sciutto
Journal:  J Neuropathol Exp Neurol       Date:  2020-02-01       Impact factor: 3.685

Review 2.  A Quick Guide to Small-Molecule Inhibitors of Eukaryotic Protein Synthesis.

Authors:  S E Dmitriev; D O Vladimirov; K A Lashkevich
Journal:  Biochemistry (Mosc)       Date:  2020-11       Impact factor: 2.487

3.  Suppression of eIF2α kinases alleviates Alzheimer's disease-related plasticity and memory deficits.

Authors:  Tao Ma; Mimi A Trinh; Alyse J Wexler; Clarisse Bourbon; Evelina Gatti; Philippe Pierre; Douglas R Cavener; Eric Klann
Journal:  Nat Neurosci       Date:  2013-08-11       Impact factor: 24.884

Review 4.  Use of okadaic acid to identify relevant phosphoepitopes in pathology: a focus on neurodegeneration.

Authors:  Miguel Medina; Jesús Avila; Nieves Villanueva
Journal:  Mar Drugs       Date:  2013-05-21       Impact factor: 5.118

Review 5.  PKR involvement in Alzheimer's disease.

Authors:  Jacques Hugon; François Mouton-Liger; Julien Dumurgier; Claire Paquet
Journal:  Alzheimers Res Ther       Date:  2017-10-05       Impact factor: 6.982

6.  Carbonyl-protein content increases in brain and blood of female rats after chronic oxycodone treatment.

Authors:  Ruping Fan; Lisa M Schrott; Stephen Snelling; John Felty; Derrel Graham; Patrick L McGauly; Thomas Arnold; Nadejda L Korneeva
Journal:  BMC Neurosci       Date:  2020-01-22       Impact factor: 3.288

7.  PKR kinase directly regulates tau expression and Alzheimer's disease-related tau phosphorylation.

Authors:  Lasse Reimer; Cristine Betzer; Rikke Hahn Kofoed; Christiane Volbracht; Karina Fog; Chaitanya Kurhade; Emma Nilsson; Anna K Överby; Poul Henning Jensen
Journal:  Brain Pathol       Date:  2020-08-06       Impact factor: 6.508

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.